Cheryl Arrowsmith

Cheryl H. Arrowsmith is a Canadian structural biologist and is the Chief Scientist at the Toronto laboratory of the Structural Genomics Consortium. Her contributions to protein structural biology includes the use of NMR and X-ray crystallography to pursue structures of proteins on a proteome wide scale.

She received her Ph.D. in chemistry at the University of Toronto in 1987 and post-doctoral training at Stanford University working with Oleg Jardetzky. One of her areas of interest is the tumour suppressor p53 and related proteins.

Her current research is to determine the 3-dimensional structures of human proteins of therapeutic relevance by structural proteomics. She has made significant contributions to epigenetic signaling in the context of drug discovery.

Arrowsmith was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2015. She was also named as one of the Clarivate Highly Cited Researchers in 2023.